ALMS
ALMS
NASDAQ · Pharmaceuticals

Alumis Inc

$24.51
-0.09 (-0.37%)
Financial Highlights (FY 2026)
Revenue
36.05M
Net Income
-364,831,043
Gross Margin
Profit Margin
-1,011.8%
Rev Growth
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 62.0% 62.0% 62.0%
Operating Margin -1,105.6% 19.3% 20.1% 18.6%
Profit Margin -1,011.8% 13.7% 18.2% 15.3%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 36.05M 878.33M 917.39M 923.52M
Gross Profit 544.48M 568.69M 572.49M
Operating Income -398,621,105 169.52M 184.08M 171.32M
Net Income -364,831,043 120.27M 166.79M 141.53M
Gross Margin 62.0% 62.0% 62.0%
Operating Margin -1,105.6% 19.3% 20.1% 18.6%
Profit Margin -1,011.8% 13.7% 18.2% 15.3%
Rev Growth +6.0% +16.1% -7.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 414.28M 427.86M 516.43M
Total Equity 1.64B 1.41B 1.63B
D/E Ratio 0.25 0.30 0.32
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -393,440,243 272.46M 241.94M 249.41M
Free Cash Flow 126.96M 147.40M 173.90M